Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis ; volume:7 ; number:1 ; day:18 ; month:11 ; year:2019 ; pages:133-147 ; date:3.2020
Rheumatology and therapy ; 7, Heft 1 (18.11.2019), 133-147, 3.2020
- Creator
-
Spivey, Christina A.
Winthrop, Kevin L.
Griffith, Jenny
Kaplan, Cameron M.
Qiao, Yanru
Postlethwaite, Arnold E.
Wang, Junling
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-019-00184-5
- URN
-
urn:nbn:de:101:1-2020051301124043137314
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spivey, Christina A.
- Winthrop, Kevin L.
- Griffith, Jenny
- Kaplan, Cameron M.
- Qiao, Yanru
- Postlethwaite, Arnold E.
- Wang, Junling
- SpringerLink (Online service)
Other Objects (12)
A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Impact of Online Prescription Management Systems on Biologic Treatment Initiation
Timing of vasoactive agents and corticosteroid initiation in septic shock
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H
Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease
Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration
Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
Limited efficacy of adalimumab in the acute phase of serpiginous choroiditis refractory to corticosteroid and cyclosporine, a case report
A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Impact of Online Prescription Management Systems on Biologic Treatment Initiation
Timing of vasoactive agents and corticosteroid initiation in septic shock
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H
Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease
Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration
Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
Limited efficacy of adalimumab in the acute phase of serpiginous choroiditis refractory to corticosteroid and cyclosporine, a case report
A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Impact of Online Prescription Management Systems on Biologic Treatment Initiation
Timing of vasoactive agents and corticosteroid initiation in septic shock
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H
Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease
Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration
Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis